Kyverna Therapeutics
2 articles with Kyverna Therapeutics
-
Kyverna Therapeutics Announces the Appointment of James Chung, M.D., Ph.D., as Chief Medical Officer
4/13/2021
Dr. Chung brings nearly 20 years' experience as a leader in autoimmune disease drug development with expertise in rheumatology, autoimmunity, and immunology Company also names world's leading immunology experts to Scientific Advisory Board
-
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.